ABOS / Acumen Pharmaceuticals, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Acumen Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US00509G2093

Deler fremragende 72,227,580 shares
Insideraktier26.226.068 shares
Insider ejerskab36,31 %
Total Insiders19
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

-1 ( )
9462 out of 10951

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

-0.006% ( )
9375 out of 10791

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Acumen Pharmaceuticals, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Russell Barton Chief Operating Officer - [O] 205.092 205.092
Doherty James J. President and CDO - [O] 220.900 220.900
Kimberlee C Drapkin Director - [D] 12.800 12.800
Nathan B Fountain Director - [D] 19.050 19.050
Hardie Robert D. 10% Owner - [10%] 657.985 657.985
Ives Jeffrey L. Director - [D] 12.800 12.800
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Paul B Manning 10% Owner - [10%] 657.985 657.985
Derek M Meisner Chief Legal Officer & Corp Sec - [O] 173.999 173.999
Daniel Joseph OConnell Chief Executive Officer, Director - [D] [O] 881.275 881.275
Derrell Porter Director - [D] 12.800 12.800
Ra Capital Management, Llc Director, 10% Owner - [D] [10%] 19.103.785 19.103.785
Sands Frank M. 10% Owner - [10%] 3.417.075 3.417.075
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Sands Capital Ventures Discovery Fund III, L.P. 10% Owner - [10%] 3.417.075 3.417.075
Amy Schacterle Chief Regulatory Officer - [O] 92.303 92.303
Shah Rajeev M. Director, 10% Owner - [D] [10%] 588.850 19.103.785
Eric Siemers Chief Medical Officer - [O] 255.371 255.371
Sean Stalfort Director - [D] 185.124 185.124
Laura Stoppel Director - [D] 12.800 12.800
Matt Zuga CFO & Chief Business Officer - [O] 304.924 304.924

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ABOS / Acumen Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2023-07-21 RA CAPITAL MANAGEMENT, LLC 5.161.290 7,7500 5.161.290 7,7500 39.999.998 0 7.4000 -1.806.451 -4,52
2021-07-06 Stalfort Sean 35.000 16,0000 35.000 16,0000 560.000
2021-07-06 Hardie Robert D. 312.500 16,0000 312.500 16,0000 5.000.000
2021-07-06 RA CAPITAL MANAGEMENT, LLC 115.668 16,0000 115.668 16,0000 1.850.688
2021-07-06 RA CAPITAL MANAGEMENT, LLC 1.759.332 16,0000 1.759.332 16,0000 28.149.312
2021-07-06 Hardie Robert D. 750.000 16,0000 750.000 16,0000 12.000.000
2021-07-06 Sands Capital Ventures Discovery Fund III, L.P. 450.000 14,8800 450.000 14,8800 6.696.000
2021-07-06 Fountain Nathan B 6.250 16,0000 6.250 16,0000 100.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ABOS / Acumen Pharmaceuticals, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ABOS / Acumen Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ABOS / Acumen Pharmaceuticals, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2026-03-18 2026-03-16 4 RA CAPITAL MANAGEMENT, LLC See footnotes ABOS Common Stock A - Award I 3,3000 6.060.606 20.000 19.103.785
2026-03-10 2026-03-06 4 Meisner Derek M ABOS Common Stock S - Sale D 3,2600 -2.090 -7 173.999
2026-03-10 2026-03-06 4 Meisner Derek M ABOS Common Stock M - Exercise D 1,8500 2.090 4 176.089
2026-03-03 2026-02-27 4 Meisner Derek M ABOS Common Stock S - Sale D 3,0099 -9.406 -28 173.999
2026-03-03 2026-02-27 4 Meisner Derek M ABOS Common Stock M - Exercise D 1,8500 9.406 17 183.405
2026-01-28 2026-01-28 4 Meisner Derek M ABOS Common Stock S - Sale D 3,0016 -2.671 -8 173.999
2026-01-28 2026-01-28 4 Meisner Derek M ABOS Common Stock M - Exercise D 1,8500 2.671 5 176.670
2026-01-28 2026-01-26 4 Meisner Derek M ABOS Common Stock S - Sale D 3,0005 -15.085 -45 173.999
2026-01-28 2026-01-26 4 Meisner Derek M ABOS Common Stock M - Exercise D 1,8500 15.085 28 189.084
2026-01-23 2026-01-22 4 Siemers Eric ABOS Common Stock S - Sale D 1,8200 -895 -2 255.371
2026-01-23 2026-01-21 4 Siemers Eric ABOS Common Stock S - Sale D 1,8035 -2.331 -4 256.266
2026-01-23 2026-01-23 4 Meisner Derek M ABOS Common Stock S - Sale D 1,9027 -5.633 -11 173.999
2026-01-23 2026-01-22 4 Meisner Derek M ABOS Common Stock S - Sale D 1,8400 -1.054 -2 179.632
2026-01-23 2026-01-21 4 Meisner Derek M ABOS Common Stock S - Sale D 1,8083 -2.247 -4 180.686
2026-01-23 2026-01-22 4 Zuga Matt ABOS Common Stock S - Sale D 1,8600 -1.687 -3 304.924
2026-01-23 2026-01-21 4 Zuga Matt ABOS Common Stock S - Sale D 1,8072 -2.473 -4 306.611
2026-01-23 2026-01-22 4 Barton Russell ABOS Common Stock S - Sale D 1,8400 -462 -1 205.092
2026-01-23 2026-01-21 4 Barton Russell ABOS Common Stock S - Sale D 1,8060 -2.315 -4 205.554
2026-01-23 2026-01-22 4 OConnell Daniel Joseph ABOS Common Stock S - Sale D 1,8838 -2.689 -5 881.275
2026-01-23 2026-01-21 4 OConnell Daniel Joseph ABOS Common Stock S - Sale D 1,8112 -9.346 -17 883.964
2026-01-21 2026-01-16 4 Zuga Matt ABOS Common Stock A - Award D 99.133 309.084
2026-01-21 2026-01-20 4 OConnell Daniel Joseph ABOS Common Stock A - Award D 299.800 893.310
2026-01-21 2026-01-16 4 Meisner Derek M ABOS Common Stock A - Award D 99.133 182.933
2026-01-21 2026-01-16 4 Siemers Eric ABOS Common Stock A - Award D 99.133 258.597
2026-01-21 2026-01-16 4 Barton Russell ABOS Common Stock A - Award D 84.600 207.869
2026-01-21 2026-01-16 4 Schacterle Amy ABOS Common Stock A - Award D 84.600 92.303
2026-01-21 2026-01-16 4 Doherty James J. ABOS Common Stock A - Award D 166.867 220.900
2026-01-12 2026-01-08 4 Barton Russell ABOS Common Stock S - Sale D 1,8588 -3.530 -7 123.269
2026-01-12 2026-01-08 4 Zuga Matt ABOS Common Stock S - Sale D 1,8166 -6.888 -13 209.951
2026-01-12 2026-01-12 4 Meisner Derek M ABOS Common Stock S - Sale D 1,7148 -8.548 -15 83.800
2026-01-12 2026-01-09 4 Meisner Derek M ABOS Common Stock S - Sale D 1,7633 -5.200 -9 92.348
2026-01-12 2026-01-08 4 Meisner Derek M ABOS Common Stock S - Sale D 1,8233 -30.092 -55 97.548
2026-01-12 2026-01-08 4 Meisner Derek M ABOS Common Stock S - Sale D 1,8154 -6.819 -12 127.640
2026-01-12 2026-01-12 4 OConnell Daniel Joseph ABOS Common Stock S - Sale D 1,7273 -5.388 -9 593.510
2026-01-12 2026-01-09 4 OConnell Daniel Joseph ABOS Common Stock S - Sale D 1,7643 -12.941 -23 598.898
2026-01-12 2026-01-08 4 OConnell Daniel Joseph ABOS Common Stock S - Sale D 1,8194 -8.143 -15 611.839
2026-01-09 2026-01-08 4 Doherty James J. ABOS Common Stock S - Sale D 1,8198 -6.467 -12 54.033
2026-01-09 2026-01-07 4 Doherty James J. ABOS Common Stock S - Sale D 1,9879 -1.700 -3 60.500
2026-01-09 2026-01-07 4 Schacterle Amy ABOS Common Stock S - Sale D 1,9838 -1.097 -2 7.703
2026-01-07 2026-01-07 4 OConnell Daniel Joseph ABOS Common Stock S - Sale D 1,9860 -37.755 -75 619.982
2026-01-07 2026-01-06 4 OConnell Daniel Joseph ABOS Common Stock S - Sale D 1,9662 -5.102 -10 657.737
2026-01-07 2026-01-05 4 OConnell Daniel Joseph ABOS Common Stock S - Sale D 1,9710 -4.649 -9 662.839
2026-01-07 2026-01-07 4 Zuga Matt ABOS Common Stock S - Sale D 1,9862 -1.700 -3 216.839
2026-01-07 2026-01-07 4 Zuga Matt ABOS Common Stock S - Sale D 1,9950 -4.105 -8 218.539
2026-01-07 2026-01-06 4 Zuga Matt ABOS Common Stock S - Sale D 1,9662 -5.100 -10 222.644
2026-01-07 2026-01-05 4 Zuga Matt ABOS Common Stock S - Sale D 1,9606 -4.000 -8 227.744
2026-01-07 2026-01-06 4 Siemers Eric ABOS Common Stock S - Sale D 1,9670 -6.834 -13 159.464
2026-01-07 2026-01-05 4 Siemers Eric ABOS Common Stock S - Sale D 1,9587 -4.000 -8 166.298
2026-01-07 2026-01-07 4 Barton Russell ABOS Common Stock S - Sale D 1,9871 -1.700 -3 126.799
2026-01-07 2026-01-06 4 Barton Russell ABOS Common Stock S - Sale D 1,9664 -3.618 -7 128.499
2026-01-07 2026-01-05 4 Barton Russell ABOS Common Stock S - Sale D 1,9581 -4.000 -8 132.117
2026-01-07 2026-01-07 4 Meisner Derek M ABOS Common Stock S - Sale D 1,9896 -10.070 -20 134.459
2026-01-07 2026-01-07 4 Meisner Derek M ABOS Common Stock S - Sale D 1,9876 -1.700 -3 144.529
2026-01-07 2026-01-06 4 Meisner Derek M ABOS Common Stock S - Sale D 1,9670 -3.801 -7 146.229
2026-01-07 2026-01-06 4 Meisner Derek M ABOS Common Stock S - Sale D 1,9672 -7.097 -14 150.030
2026-01-07 2026-01-05 4 Meisner Derek M ABOS Common Stock S - Sale D 1,9595 -4.000 -8 157.127
2025-06-05 2025-06-04 4 RA CAPITAL MANAGEMENT, LLC See footnotes ABOS Common Stock A - Award I 12.800 12.800
2025-06-05 2025-06-04 4 Stoppel Laura ABOS Common Stock A - Award D 12.800 12.800
2025-06-05 2025-06-04 4 Stalfort Sean ABOS Common Stock A - Award D 12.800 185.124
2025-06-05 2025-06-04 4 Drapkin Kimberlee C ABOS Common Stock A - Award D 12.800 12.800
2025-06-05 2025-06-04 4 Fountain Nathan B ABOS Common Stock A - Award D 12.800 19.050
2025-06-05 2025-06-04 4 Ives Jeffrey L. ABOS Common Stock A - Award D 12.800 12.800
2025-06-05 2025-06-04 4 Porter Derrell ABOS Common Stock A - Award D 12.800 12.800
2025-01-23 2025-01-23 4 Zuga Matt ABOS Common Stock S - Sale D 1,7173 -28.902 -50 231.744
2025-01-23 2025-01-21 4 Zuga Matt ABOS Common Stock S - Sale D 1,6009 -4.364 -7 260.646
2025-01-23 2025-01-21 4 OConnell Daniel Joseph ABOS Common Stock S - Sale D 1,5930 -12.619 -20 667.488
2025-01-23 2025-01-21 4 Meisner Derek M ABOS Common Stock S - Sale D 1,5900 -3.418 -5 161.127
2025-01-23 2025-01-21 4 Barton Russell ABOS Common Stock S - Sale D 1,6102 -2.914 -5 136.117
2025-01-23 2025-01-21 4 Siemers Eric ABOS Common Stock S - Sale D 1,5900 -3.219 -5 170.298
2025-01-07 2025-01-07 4 OConnell Daniel Joseph ABOS Common Stock A - Award D 225.400 680.107
2025-01-07 2025-01-03 4 OConnell Daniel Joseph ABOS Common Stock S - Sale D 1,8392 -47.778 -88 454.707
2025-01-07 2025-01-06 4 Schacterle Amy ABOS Common Stock A - Award D 8.800 8.800
2025-01-07 2025-01-06 4 Doherty James J. ABOS Common Stock A - Award D 62.600 62.600
2025-01-07 2025-01-06 4 Meisner Derek M ABOS Common Stock A - Award D 66.800 164.545
2025-01-07 2025-01-03 4 Meisner Derek M ABOS Common Stock S - Sale D 1,8437 -11.122 -21 97.745
2025-01-07 2025-01-06 4 Barton Russell ABOS Common Stock A - Award D 49.800 139.031
2025-01-07 2025-01-03 4 Barton Russell ABOS Common Stock S - Sale D 1,8629 -7.636 -14 89.231
2025-01-07 2025-01-06 4 Zuga Matt ABOS Common Stock A - Award D 66.800 265.010
2025-01-07 2025-01-03 4 Zuga Matt ABOS Common Stock S - Sale D 1,8411 -13.235 -24 198.210
2025-01-07 2025-01-06 4 Siemers Eric ABOS Common Stock A - Award D 66.800 173.517
2025-01-07 2025-01-03 4 Siemers Eric ABOS Common Stock S - Sale D 1,8461 -10.859 -20 106.717
2024-01-19 2024-01-19 4 OConnell Daniel Joseph ABOS Common Stock S - Sale D 3,4706 -15.200 -53 502.485
2024-01-19 2024-01-19 4 Meisner Derek M ABOS Common Stock S - Sale D 3,4757 -8.933 -31 108.867
2024-01-19 2024-01-18 4 Siemers Eric ABOS Common Stock S - Sale D 3,7144 -3.124 -12 117.576
2024-01-19 2024-01-18 4 Zuga Matt ABOS Common Stock S - Sale D 3,7050 -4.242 -16 211.445
2024-01-19 2024-01-18 4 Barton Russell ABOS Common Stock S - Sale D 3,7258 -2.833 -11 96.867
2024-01-04 2024-01-02 4 Barton Russell ABOS Common Stock A - Award D 73.000 99.700
2024-01-04 2024-01-02 4 Meisner Derek M ABOS Common Stock A - Award D 91.000 117.800
2024-01-04 2024-01-02 4 Siemers Eric ABOS Common Stock A - Award D 94.000 120.700
2024-01-04 2024-01-02 4 Zuga Matt ABOS Common Stock A - Award D 106.000 215.687
2024-01-04 2024-01-02 4 OConnell Daniel Joseph ABOS Common Stock A - Award D 401.000 517.685
2023-08-18 2023-08-17 4 Ives Jeffrey L. ABOS Common Stock S - Sale D 6,6600 -2.800 -19 0
2023-08-18 2023-08-17 4 Ives Jeffrey L. ABOS Common Stock M - Exercise D 1,1900 2.800 3 2.800
2023-08-18 2023-08-17 4 Ives Jeffrey L. ABOS Common Stock S - Sale D 6,4800 -39.149 -254 0
2023-08-18 2023-08-17 4 Ives Jeffrey L. ABOS Common Stock M - Exercise D 0,7200 39.149 28 39.149
2023-07-25 2023-07-21 4 RA CAPITAL MANAGEMENT, LLC See Footnotes ABOS Common Stock P - Purchase I 7,7500 5.161.290 40.000 13.043.179
2023-01-18 2023-01-17 4 Meisner Derek M ABOS Common Stock A - Award D 26.800 26.800
2023-01-18 2023-01-17 4 Zuga Matt ABOS Common Stock A - Award D 33.500 109.687
2023-01-18 2023-01-17 4 Barton Russell ABOS Common Stock A - Award D 26.700 26.700
2023-01-18 2023-01-17 4 Siemers Eric ABOS Common Stock A - Award D 26.700 26.700
2023-01-18 2023-01-17 4 OConnell Daniel Joseph ABOS Common Stock A - Award D 114.000 116.685
2023-01-03 2022-12-29 4 Zuga Matt ABOS Common Stock M - Exercise D 1,1900 50.000 60 76.187
2022-04-04 2022-04-01 4 Drapkin Kimberlee C ABOS Stock Option Grant (right to buy) A - Award D 4,01 50.000 50.000
2022-01-21 2022-01-19 4 Zuga Matt ABOS Employee Stock Option (right to buy) A - Award D 5,19 150.000 150.000
2022-01-21 2022-01-19 4 Siemers Eric ABOS Employee Stock Option (right to buy) A - Award D 5,19 90.000 90.000
2022-01-21 2022-01-19 4 OConnell Daniel Joseph ABOS Employee Stock Option (right to buy) A - Award D 5,19 455.000 455.000
2022-01-21 2022-01-19 4 Barton Russell ABOS Employee Stock Option (right to buy) A - Award D 5,19 135.000 135.000
2021-12-02 2021-11-30 4 OConnell Daniel Joseph ABOS Stock Option (Right to Buy) M - Exercise D 4,47 -1.118 0
2021-12-02 2021-11-30 4 OConnell Daniel Joseph ABOS Common Stock M - Exercise D 4,4700 1.118 5 2.685
2021-07-08 2021-07-06 4 Manning Paul B ABOS Series B Preferred Stock C - Conversion I -657.985 0
2021-07-08 2021-07-06 4 Manning Paul B ABOS Series B Preferred Stock C - Conversion I -1.315.969 0
2021-07-08 2021-07-06 4 Manning Paul B ABOS Series A-1 Preferred Stock C - Conversion I -1.634.515 0
2021-07-08 2021-07-06 4 Manning Paul B ABOS Common Stock C - Conversion I 657.985 657.985
2021-07-08 2021-07-06 4 Manning Paul B ABOS Common Stock P - Purchase I 16,0000 312.500 5.000 3.352.693
2021-07-08 2021-07-06 4 Manning Paul B ABOS Common Stock C - Conversion I 2.950.484 3.040.193
2021-07-08 2021-07-06 4 Zuga Matt ABOS Series B Preferred Stock C - Conversion D -10.528 10.528
2021-07-08 2021-07-06 4 Zuga Matt ABOS Series A-1 Preferred Stock C - Conversion D -15.659 15.659
2021-07-08 2021-07-06 4 Zuga Matt ABOS Common Stock C - Conversion D 26.187 26.187
2021-07-08 2021-07-06 4 OConnell Daniel Joseph ABOS Warrant (Right to Buy) M - Exercise D 4,47 -35 0
2021-07-08 2021-07-06 4 OConnell Daniel Joseph ABOS Series A Preferred Stock C - Conversion D -123 0
2021-07-08 2021-07-06 4 OConnell Daniel Joseph ABOS Common Stock F - Taxes D 16,0000 -10 -0 1.567
2021-07-08 2021-07-06 4 OConnell Daniel Joseph ABOS Common Stock X - Other D 4,4700 35 0 1.577
2021-07-08 2021-07-06 4 OConnell Daniel Joseph ABOS Common Stock C - Conversion D 123 1.542
2021-07-08 2021-07-06 4 Stalfort Sean ABOS Series B Preferred C - Conversion I -131.595 0
2021-07-08 2021-07-06 4 Stalfort Sean ABOS Series A-1 Preferred C - Conversion D -130.180 0
2021-07-08 2021-07-06 4 Stalfort Sean ABOS Common Stock C - Conversion I 131.595 131.595
2021-07-08 2021-07-06 4 Stalfort Sean ABOS Common Stock P - Purchase D 16,0000 35.000 560 172.324
2021-07-08 2021-07-06 4 Stalfort Sean ABOS Common Stock C - Conversion D 130.180 137.324
2021-07-08 2021-07-06 4 Hardie Robert D. ABOS Series B Preferred Stock C - Conversion I -657.985 0
2021-07-08 2021-07-06 4 Hardie Robert D. ABOS Series B Preferred Stock C - Conversion I -1.315.969 0
2021-07-08 2021-07-06 4 Hardie Robert D. ABOS Series A-1 Preferred Stock C - Conversion I -1.634.515 0
2021-07-08 2021-07-06 4 Hardie Robert D. ABOS Common Stock C - Conversion I 657.985 657.985
2021-07-08 2021-07-06 4 Hardie Robert D. ABOS Common Stock P - Purchase I 16,0000 312.500 5.000 3.352.693
2021-07-08 2021-07-06 4 Hardie Robert D. ABOS Common Stock C - Conversion I 2.950.484 3.040.193
2021-07-08 2021-07-06 4 Fountain Nathan B ABOS Common Stock P - Purchase D 16,0000 6.250 100 6.250
2021-07-08 2021-07-06 4 Hardie Robert D. ABOS Series B Preferred Stock C - Conversion I -2.076.326 0
2021-07-08 2021-07-06 4 Hardie Robert D. ABOS Series A-1 Preferred Stock C - Conversion I -1.124.830 0
2021-07-08 2021-07-06 4 Hardie Robert D. ABOS Common Stock P - Purchase I 16,0000 750.000 12.000 3.951.156
2021-07-08 2021-07-06 4 Hardie Robert D. See footnotes ABOS Common Stock C - Conversion I 2.076.326 3.201.156
2021-07-08 2021-07-06 4 Hardie Robert D. ABOS Common Stock C - Conversion I 1.124.830 1.124.830
2021-07-08 2021-07-06 4 Sands Capital Ventures Discovery Fund III, L.P. ABOS Series B Preferred Stock C - Conversion D -1.842.346 0
2021-07-08 2021-07-06 4 Sands Capital Ventures Discovery Fund III, L.P. ABOS Series A-1 Preferred Stock C - Conversion D -1.124.729 0
2021-07-08 2021-07-06 4 Sands Capital Ventures Discovery Fund III, L.P. ABOS Common Stock P - Purchase D 14,8800 450.000 6.696 3.417.075
2021-07-08 2021-07-06 4 Sands Capital Ventures Discovery Fund III, L.P. ABOS Common Stock C - Conversion D 1.842.346 2.967.075
2021-07-08 2021-07-06 4 Sands Capital Ventures Discovery Fund III, L.P. ABOS Common Stock C - Conversion D 1.124.729 1.124.729
2021-07-08 2021-07-06 4 RA CAPITAL MANAGEMENT, LLC See footnotes ABOS Series B Preferred Stock C - Conversion I -588.850 0
2021-07-08 2021-07-06 4 RA CAPITAL MANAGEMENT, LLC See footnotes ABOS Series B Preferred Stock C - Conversion I -1.184.366 0
2021-07-08 2021-07-06 4 RA CAPITAL MANAGEMENT, LLC See footnotes ABOS Series B Preferred Stock C - Conversion I -6.122.557 0
2021-07-08 2021-07-06 4 RA CAPITAL MANAGEMENT, LLC See footnotes ABOS Common Stock C - Conversion I 588.850 588.850
2021-07-08 2021-07-06 4 RA CAPITAL MANAGEMENT, LLC See footnotes ABOS Common Stock P - Purchase I 16,0000 115.668 1.851 1.300.034
2021-07-08 2021-07-06 4 RA CAPITAL MANAGEMENT, LLC See footnotes ABOS Common Stock C - Conversion I 1.184.366 1.184.336
2021-07-08 2021-07-06 4 RA CAPITAL MANAGEMENT, LLC See footnotes ABOS Common Stock P - Purchase I 16,0000 1.759.332 28.149 7.881.889
2021-07-08 2021-07-06 4 RA CAPITAL MANAGEMENT, LLC See footnotes ABOS Common Stock C - Conversion I 6.122.557 6.122.557
2021-07-02 2021-06-30 4 Ives Jeffrey L. ABOS Stock Option (Right to Buy) A - Award D 16,00 34.000 34.000
2021-07-02 2021-06-30 4 Stalfort Sean ABOS Stock Option (Right to Buy) A - Award D 16,00 34.000 34.000
2021-07-02 2021-06-30 4 Sevigny Jeffrey ABOS Stock Option (Right to Buy) A - Award D 16,00 34.000 34.000
2021-07-02 2021-06-30 4 Fountain Nathan B ABOS Stock Option (Right to Buy) A - Award D 16,00 34.000 34.000
2021-07-02 2021-06-30 4 Stoppel Laura ABOS Stock Option (Right to Buy) A - Award D 16,00 34.000 34.000
2021-06-30 3 Manning Paul B See Footnotes ABOS Common Stock I 89.709
2021-06-30 3 Stalfort Sean ABOS Common Stock D 7.144
2021-06-30 3 OConnell Daniel Joseph ABOS Common Stock D 1.419
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista